News-Papers
Testimonial
Video Gallery
Clinical importance of melatonin
Published on Tuesday, 26 June 2018
Clinical importance of melatonin
See also:
- The Di Bella Method (A Fixed Part - Melatonin tablets);
- Complete objective response to biological therapy of plurifocal breast carcinoma.
Search
Follow us...
Latest
- Synergistic Cytotoxicity of Melatonin and New-generation Anticancer Drugs Against Leukemia Lymphocytes But Not Normal Lymphocytes
- Promising Antineoplastic Actions of Melatonin
- Melatonin potentiates chemotherapy-induced cytotoxicity and apoptosis in rat pancreatic tumor cells
- The role of melatonin in colorectal cancer treatment: a comprehensive review
- The oncogenic potential of growth hormone
- The oncogenic potential of autocrine human growth hormone in breast cancer
- Targeting cancer vulnerabilities with high-dose vitamin C
- Somatostatin analogs for cancer treatment and diagnosis: an overview
- Radiomitigation by Melatonin in C57BL/6 Mice: Possible Implications as Adjuvant in Radiotherapy and Chemotherapy
- Radiation-Induced Dual Oxidase Upregulation in Rat Heart Tissues: Protective Effect of Melatonin
- Protective effect of melatonin against radiation induced nephrotoxicity in rats
- Physiological melatonin inhibition of human breast cancer cell growth in vitro: evidence for a glutathione-mediated pathway
- Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone
- Somatostatin in oncology, the overlooked evidences
- Oral administration of melatonin modulates the expression of tumor necrosis factor-α (TNF-α) gene in irradiated rat cervical spinal cord
- Melatonin protection from chronic, low-level ionizing radiation
- Melatonin Attenuates Upregulation of Duox1 and Duox2 and Protects against Lung Injury following Chest Irradiation in Rats
- Melatonin prevents inflammation and oxidative stress caused by abdominopelvic and total body irradiation of rat small intestine
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Somatostatin in oncology, the overlooked evidences
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- How effective is chemo therapy?
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Bibliography
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer